Home | Publications | Country | Europe (West) | Spain place holder
place holder place holder

Spain

Medicated Skincare in Spain


Publication Date   November 2005
Publisher   Euromonitor International
Product Type   Article
Pages   46
ISBN Number   not applicable
Product Code   EUR475
Ask a question about this product?

Price £450.00

approximately: $841 | €571

Summary


Medicated Skin Care in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (1999-2004), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2009 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?
  • Get a detailed picture of the analgesics industry

  • Pinpoint growth sectors and trends and identify factors driving change

  • Understand the competitive environment, the market’s major players and leading brands

  • Use five-year forecasts to assess how the market is predicted to develop

Content


Medicated Skin Care in Spain


1. EXECUTIVE SUMMARY


2. OPERATING ENVIRONMENT

2.1 OTC Registration and Classification
2.2 Advertising
Table 1 Advertising Expenditure on EFP and Other Parapharmaceutical Products by Medium 1997-2003
2.3 Packaging and Labelling
2.4 Distribution
2.5 De-listing or De-reimbursement
2.6 Traditional Remedies
2.7 Homeopathy
2.8 Generics
2.9 Consumer Expenditure on Health Goods and Medical Services
Table 2 Consumer Expenditure on Health Goods and Medical Services 1999-2003
2.10 Life Expectancy
Table 3 Life Expectancy at Birth 1999-2004

3. OTC HEALTHCARE SALES

3.1 Market Performance
Table 4 Sales of OTC Healthcare by Sector: Value 1999-2004
Table 5 Sales of OTC Healthcare by Sector: % Value Growth 1999-2004
3.2 Switches
Summary 1 OTC Healthcare Switches 2003-2004
3.3 Key Trends and Developments
3.4 Competitive Environment
Table 6 OTC Healthcare Company Shares 2001-2004
Table 7 OTC Healthcare Brand Shares 2001-2004
3.5 Leading Company Profiles – Almirall Prodesfarma SA
Summary 2 Almirall Prodesfarma SA Operational Indicators 2004
Table 8 Almirall Prodesfarma SA Shares of OTC Healthcare by Subsector 2001-2004
3.6 Química Farmacéutica Bayer SA
Summary 3 Química Farmacéutica Bayer SA Operational Indicators 2003
Summary 4 Química Farmacéutica Bayer SA: Production Statistics 2003
Table 9 Química Farmacéutica Bayer SA: Shares of OTC Healthcare by Subsector 2001-2004
3.7 Leading Company Profiles - Boehringer Ingelheim España SA
Summary 5 Boehringer Ingelheim España SA Operational Indicators 2003
Table 10 Boehringer Ingelheim España SA Shares of OTC Healthcare by Subsector 2001-2004
3.8 Leading Company Profiles – Boots Healthcare Iberia
Table 11 Boots Healthcare Iberia SA Shares of OTC Healthcare by Subsector 2001-2004
3.9 Leading Company Profiles – GlaxoSmithKline SA
Table 12 GlaxoSmithKline SA Shares of OTC Healthcare by Subsector 2001-2004
3.10 Leading Company Profiles – Johnson & Johnson SA
Table 13 Johnson & Johnson SA Shares of OTC Healthcare by Subsector 2001-2004
3.11 Leading Company Profiles – Merck Farma y Química SA
Summary 6 Merck KgaA Operational Indicators 2004
Table 14 Merck Farma y QuĂ­mica SA Shares of OTC Healthcare by Subsector 2001-2004
3.12 Leading Company Profiles - Novartis Consumer Health SA
Summary 7 Novartis SA Operational Indicators 2004
Summary 8 Novartis Consumer Health SA: Production Statistics 2003
Table 15 Novartis Consumer Health SA Shares of OTC Healthcare by Subsector 2001-2004
3.13 Leading Companies - Pfizer SA
Summary 9 Pfizer SA Operational Indicators 2003
Table 16 Pfizer SA Shares of OTC Healthcare by Subsector 2001-2004
3.14 Leading Company Profiles – Productos Roche SA
Summary 10 Productos Roche SA Operational Indicators 2003
Table 17 Productos Roche SA Shares of OTC Healthcare by Subsector 2001-2004
3.15 Leading Company Profiles – Uriach OTC
Table 18 Uriach OTC Shares of OTC Healthcare by Subsector 2001-2004
3.16 Leading Company Profiles – Viatris Pharmaceuticals SA
Table 19 Viatris Pharmaceuticals SA Shares of OTC Healthcare by Subsector 2001-2004
3.17 Emerging and Niche Companies
3.18 Retail Distribution
Table 20 Sales of OTC Healthcare by Distribution Format: % Analysis 1999/2004
Table 21 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2004
3.19 Retailer Activity and Private Label Trends
Table 22 Penetration of Private Label by Sector 2001-2004
3.20 Forecast Market Performance
Table 23 Forecast Sales of OTC Healthcare by Sector: Value 2004-2009
Table 24 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2004-2009

4. MEDICATED SKIN CARE SALES

4.1 Sector Performance
Table 25 Sales of Medicated Skin Care by Subsector: Value 1999-2004
Table 26 Sales of Medicated Skin Care by Subsector: % Value Growth 1999-2004
Table 27 Medicated Skin Care Company Shares 2001-2004
Table 28 Medicated Skin Care Brand Shares 2001-2004
Table 29 Forecast Sales of Medicated Skin Care by Subsector: Value 2004-2009
Table 30 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2004-2009
4.2 New Product Developments
Summary 11 Medicated Skin Care: New Product Launches 2004
4.3 Medicated Skin Care by Herbal/Standard Split
Table 31 Herbal vs Standard Medicated Skin Care 1999/2004
4.4 Acne Treatments Brand Shares
Table 32 Acne Treatments Brand Shares 2001-2004
4.5 Hair Loss treatments Brand Shares
Table 33 Hair Loss treatments Brand Shares 2001-2004

5. OTHER OTC


6. DEFINITIONS